AMG National Trust Bank’s GSK GSK Stock Holding History

AMG National Trust Bank’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-8,183	Closed	-$452K	–	466
2026 Q1	$452K	Buy	8,183 +1,820	+29%	+$98.6K	0.01%	382
2025 Q4	$312K	Buy	6,363 +201	+3%	+$9.38K	0.01%	392
2025 Q3	$266K	Sell	6,162 -2,029	-25%	-$79.3K	0.01%	410
2025 Q2	$315K	Sell	8,191 -61,004	-88%	-$2.33M	0.01%	378
2025 Q1	$2.68M	Buy	69,195 +24,584	+55%	+$900K	0.07%	157
2024 Q4	$1.5M	Sell	44,611 -12,718	-22%	-$458K	0.04%	227
2024 Q3	$2.34M	Buy	57,329 +76	+0.1%	+$3.11K	0.06%	183
2024 Q2	$2.2M	Buy	57,253 +121	+0.2%	+$5.09K	0.06%	192
2024 Q1	$2.45M	Sell	57,132 -1,371	-2%	-$56.5K	0.07%	173
2023 Q4	$2.17M	Sell	58,503 -16,145	-22%	-$580K	0.07%	175
2023 Q3	$2.71M	Sell	74,648 -1,000	-1%	-$35.5K	0.09%	143
2023 Q2	$2.7M	Sell	75,648 -1,484	-2%	-$53.2K	0.09%	145
2023 Q1	$2.74M	Buy	77,132 +12,738	+20%	+$446K	0.09%	140
2022 Q4	$2.26M	Sell	64,394 -1,873	-3%	-$62.4K	0.08%	154
2022 Q3	$1.95M	Buy	66,267 +44,369	+203%	+$1.68M	0.07%	169
2022 Q2	$1.19M	Sell	21,898 -25,868	-54%	-$1.43M	0.04%	231
2022 Q1	$2.6M	Buy	47,766 +5,861	+14%	+$318K	0.08%	149
2021 Q4	$2.31M	Buy	41,905 +52	+0.1%	+$2.71K	0.07%	171
2021 Q3	$2M	Buy	41,853 +287	+0.7%	+$14.4K	0.06%	181
2021 Q2	$2.07M	Sell	41,566 -212	-0.5%	-$10.2K	0.07%	178
2021 Q1	$1.86M	Sell	41,778 -13,736	-25%	-$623K	0.06%	187
2020 Q4	$2.55M	Buy	+55,514	New	+$2.55M	0.09%	140
2019 Q2	–	Sell	-71,450	Closed	-$3.73M	–	258
2019 Q1	$3.73M	Sell	71,450 -7,554	-10%	-$377K	0.23%	59
2018 Q4	$3.77M	Buy	79,004 +11,374	+17%	+$560K	0.26%	54
2018 Q3	$3.4M	Buy	67,630 +1,957	+3%	+$99.4K	0.2%	63
2018 Q2	$3.31M	Buy	65,673 +1,157	+2%	+$58.3K	0.21%	64
2018 Q1	$3.15M	Sell	64,516 -6,194	-9%	-$288K	0.2%	68
2017 Q4	$3.13M	Buy	70,710 +4,329	+7%	+$200K	0.2%	69
2017 Q3	$3.37M	Buy	66,381 +2,713	+4%	+$138K	0.23%	60
2017 Q2	$3.43M	Buy	63,668 +2,365	+4%	+$126K	0.25%	58
2017 Q1	$3.23M	Buy	61,303 +6,826	+13%	+$346K	0.25%	64
2016 Q4	$2.62M	Buy	54,477 +8,269	+18%	+$408K	0.22%	71
2016 Q3	$2.49M	Buy	46,208 +5,983	+15%	+$328K	0.21%	66
2016 Q2	$2.18M	Sell	40,225 -61	-0.2%	-$3.21K	0.19%	69
2016 Q1	$2.04M	Buy	40,286 +406	+1%	+$20.2K	0.19%	74
2015 Q4	$2.01M	Buy	39,880 +134	+0.3%	+$6.83K	0.18%	70
2015 Q3	$1.91M	Buy	39,746 +19,909	+100%	+$1.04M	0.18%	73
2015 Q2	$1.03M	Sell	19,837 -869	-4%	-$48.9K	0.09%	119
2015 Q1	$1.19M	Buy	20,706 +6,573	+47%	+$377K	0.11%	107
2014 Q4	$755K	Sell	14,133 -273	-2%	-$15.3K	0.08%	141
2014 Q3	$828K	Buy	14,406 +4,684	+48%	+$287K	0.09%	134
2014 Q2	$650K	Sell	9,722 -40	-0.4%	-$2.71K	0.07%	151
2014 Q1	$652K	Sell	9,762 -132	-1%	-$8.92K	0.07%	153
2013 Q4	$660K	Buy	9,894 +25	+0.3%	+$1.62K	0.07%	149
2013 Q3	$619K	Sell	9,869 -178	-2%	-$11.5K	0.08%	137
2013 Q2	$628K	Buy	+10,047	New	+$638K	0.08%	129

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

AMG National Trust Bank's GSK Position: Q2 2026 in Review

AMG National Trust Bank sold out of GSK (GSK) in Q2 2026, closing a stake of 8,183 shares — an estimated $452K sold.

AMG National Trust Bank first reported a position in GSK in Q2 2013 and held it in 46 quarters. The position peaked at $3.77M in Q4 2018. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

AMG National Trust Bank reported no remaining GSK position as of Q2 2026 after selling out during the quarter.
AMG National Trust Bank sold 8,183 GSK shares in Q2 2026, an estimated $452K.
AMG National Trust Bank first reported a position in GSK in Q2 2013 and held it in 46 quarters.
AMG National Trust Bank's GSK position peaked at $3.77M in Q4 2018.
1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on AMG National Trust Bank's 13F filing for Q2 2026, filed 7 Aug 2026.